Table 5.
This table shows the PAF for risk factors on selected outcomes.
| Exposure | Population attributable fraction (95% CI) | |||||
|---|---|---|---|---|---|---|
| Combined major complications | Major cardiac complications | Major pulmonary complications | Acute renal failure | 30-Day mortality | Critical care services admission | |
| Blood transfusion | 9.51% (9.12–9.90) | 4.77% (4.22–5.32) | 19.64% (18.41–20.86) | 29.75% (28.41–31.08) | 17.15% (12.71–21.37) | 10.90% (10.08–11.73) |
| All comorbidities | 13.40% (12.94–13.86) | 12.42% (11.75–13.07) | 21.46% (20.12–22.78) | 32.77% (31.37–34.14) | 20.66% (16.07–25.00) | 19.44% (18.47–20.40) |
| Diabetes | 3.17% (2.82–3.52) | 2.03% (1.52–2.53) | 2.55% (1.48–3.61) | 11.86% (10.59–13.11) | 5.21% (1.46–8.81) | 2.03% (1.28–2.77) |
| Sleep apnea | 3.44% (3.20–3.68) | 4.23% (3.88–4.58) | 8.47% (7.64–9.30) | 5.62% (4.73–6.50) | 2.50% (0.08–4.85) | 7.35% (6.77–7.93) |
| Obesity | 4.19% (3.85–4.53) | 2.59% (2.14–3.05) | 7.47% (6.37–8.55) | 15.94% (14.73–17.13) | 3.78% (0.63–6.83) | 7.07% (6.29–7.84) |
| Age group* (ref ≤65) | 34.70% (33.63–35.75) | 58.02% (56.85–59.16) | 15.92% (12.23–19.46) | 19.46% (15.43–23.30) | 49.54% (38.69–58.47) | 11.37% (8.78–13.89) |
| Gender*(ref= F) | 8.18% (7.63–8.72) | 19.73% (18.93–20.52) | 2.76% (1.15–4.34) | 22.73% (21.04–24.37) | 23.69% (18.07–28.92) | 6.03% (4.85–7.20) |
CI: confidence interval of the PAF.
*PAF compares the proportion of outcome to a population, where all individuals are ≤65 years or are all female for the risks age group and gender, respectively.